In addition, CD206 cross-linking with an anti-MR mAb (clone PAM-1) can drive DCs differentiation into APCs promoting T-cell anergy [28], which contributes to the failure of the immune surveillance against solid tumors and facilitates tumor growth and spreading [29], [30], [31]. This evidence concerns the gene MRC1 and neoplasm.